Biagi, M <br/><br/>
Co-administration of elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and atazanavir in treatment-experienced HIV patients.  [electronic resource] 

 -  International journal of STD & AIDS  07 2017 
 - 766-772 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1758-1052 
<br/><br/><label>Standard No.: </label>10.1177/0956462416666440  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>Atazanavir Sulfate--administration & dosage<br/>Drug Combinations<br/>Drug Therapy, Combination<br/>Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination--administration & dosage<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Treatment Outcome